The major signaling pathways that are most frequently altered in prostate cancer include androgen receptor (AR), the PI3K, Ras/Raf/MEK/ERK; and the retinoblastoma (RB) signaling pathway (Figure 2). The gene discussed is AR; the disease is prostate carcinoma.